Active Not RecruitingNCT06433635
Sequential Multiple Assignment Randomized Trial for Depression in bipolarity
Medication studyAges 18–75United States + Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- Birmingham and 17 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 2,726
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States, Canada
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT06433635
- Official title
Show the full official title
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham, United States · Bloomington, United States · Baltimore, United States
14 more locations
- Belmont, United States
- Boston, United States
- Ann Arbor, United States
- Grand Rapids, United States
- Albuquerque, United States
- New York, United States
- Chapel Hill, United States
- Cleveland, United States
- Philadelphia, United States
- Pittsburgh, United States
- Austin, United States
- Dallas, United States
- Houston, United States
- Vancouver, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Cariprazine, Aripiprazole/Escitalopram combination, Quetiapine and Lurasidone.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
